Research & Development

Medical Imaging Radiation Linked to Child Blood Cancer Risk
Research & Development Medical Imaging Radiation Linked to Child Blood Cancer Risk

As a pediatric radiologist with over two decades of experience, I’m thrilled to sit down with a leading expert in the field to discuss a critical topic: the impact of radiation from medical imaging on children’s health. Our guest today is a renowned researcher whose recent work has shed light on

Bipartisan Backing Boosts Vaccine Industry Confidence
Research & Development Bipartisan Backing Boosts Vaccine Industry Confidence

The vaccine industry in the United States finds itself at a critical juncture, where an unprecedented level of bipartisan support offers a glimmer of hope amid swirling controversies, technological debates, and regulatory uncertainties that could shape its future trajectory. A recent poll conducted

What Are the Key Cancer Breakthroughs and Challenges in 2025?
Research & Development What Are the Key Cancer Breakthroughs and Challenges in 2025?

As the world navigates through 2025, the ongoing battle against cancer reveals a landscape of remarkable triumphs juxtaposed with daunting hurdles, as detailed in the American Association for Cancer Research (AACR) Cancer Progress Report released last year. This comprehensive document captures a

Can H.R. 5239 Reduce Endometrial Cancer Disparities?
Research & Development Can H.R. 5239 Reduce Endometrial Cancer Disparities?

Endometrial cancer, the most prevalent form of uterine cancer, continues to pose a significant public health challenge, particularly due to its disproportionate impact on certain demographic groups, with a growing incidence among postmenopausal women aged 55 to 64. This disease reveals stark

Opterion Health Submits CTA for Revolutionary OPT101 Therapy
Research & Development Opterion Health Submits CTA for Revolutionary OPT101 Therapy

In a landscape where millions of patients with advanced chronic kidney disease (CKD) struggle with limited and often burdensome treatment options, a groundbreaking development has emerged to potentially transform their lives. Opterion Health AG, a clinical-stage biopharmaceutical company

STING Pathway Prodrug System – Review
Research & Development STING Pathway Prodrug System – Review

Imagine a world where cancer treatments can target tumors with pinpoint accuracy, sparing healthy tissues from harmful side effects, and bringing hope to millions. This vision is inching closer to reality with a groundbreaking technology developed by researchers at the University of Cambridge. The

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later